Advisor Group Holdings, Inc. Vericel Corp Transaction History

Advisor Group Holdings, Inc.

$42.2 Billion
Q3 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Vericel Corp stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 5,550 shares of VCEL stock, worth $327,838. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,550

Previous 4,601 20.63%

Holding current value

$327,838

Previous $211,000 10.9%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$42.25 - $53.56 $40,095 - $50,828	949 Added 20.63%	5,550 $234,000
Q2 2024 Aug 13, 2024	SELL	$41.71 - $52.9 $583,773 - $740,388	-13,996 Reduced 75.26%	4,601 $211,000
Q1 2024 May 10, 2024	SELL	$32.52 - $52.33 $188,063 - $302,624	-5,783 Reduced 23.72%	18,597 $967,000
Q4 2023 Feb 12, 2024	SELL	$30.85 - $37.09 $74,626 - $89,720	-2,419 Reduced 9.03%	24,380 $868,000
Q3 2023 Nov 13, 2023	BUY	$31.69 - $39.25 $78,559 - $97,300	2,479 Added 10.19%	26,799 $898,000
Q2 2023 Aug 10, 2023	SELL	$29.0 - $38.37 $149,089 - $197,260	-5,141 Reduced 17.45%	24,320 $913,000
Q1 2023 May 12, 2023	SELL	$23.85 - $31.34 $1,860 - $2,444	-78 Reduced 0.26%	29,461 $863,000
Q4 2022 Feb 10, 2023	SELL	$17.65 - $27.37 $10,272 - $15,929	-582 Reduced 1.93%	29,539 $778,000
Q3 2022 Nov 14, 2022	SELL	$22.62 - $32.54 $73,763 - $106,112	-3,261 Reduced 9.77%	30,121 $698,000
Q2 2022 Aug 10, 2022	BUY	$22.88 - $39.45 $69,326 - $119,533	3,030 Added 9.98%	33,382 $840,000
Q1 2022 May 04, 2022	SELL	$31.69 - $43.29 $267,083 - $364,848	-8,428 Reduced 21.73%	30,352 $3.22 Million
Q3 2021 Nov 05, 2021	SELL	$46.35 - $59.75 $7,369 - $9,500	-159 Reduced 0.41%	38,780 $1.89 Million
Q2 2021 Aug 02, 2021	BUY	$47.2 - $67.81 $76,794 - $110,326	1,627 Added 4.36%	38,939 $2.04 Million
Q1 2021 May 13, 2021	BUY	$30.93 - $59.48 $90,160 - $173,384	2,915 Added 8.47%	37,312 $2.07 Million
Q4 2020 Feb 10, 2021	SELL	$18.53 - $31.5 $131,414 - $223,398	-7,092 Reduced 17.09%	34,397 $1.06 Million
Q3 2020 Nov 12, 2020	BUY	$14.68 - $19.12 $17,557 - $22,867	1,196 Added 2.97%	41,489 $769,000
Q2 2020 Aug 14, 2020	SELL	$8.5 - $15.82 $4,309 - $8,020	-507 Reduced 1.24%	40,293 $556,000
Q1 2020 May 18, 2020	BUY	$7.25 - $19.22 $295,800 - $784,176	40,800 New	40,800 $375,000

Others Institutions Holding VCEL

# of Institutions

276

Shares Held

48.4M

Call Options Held

91.8K

Put Options Held

23.2K

View Full List

About Vericel Corp

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.79B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

More about VCEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Vericel Corp Transaction History